U.S. Biohacking Trend Sees Increased Peptide Use Despite Limited Clinical Validation
In the United States, there's a growing trend of individuals engaging in 'biohacking' by using peptides to optimize human performance and health. This practice often occurs without comprehensive clinical validation for the substances being used. The ease of access to specialized wellness centers that readily dispense prescriptions, coupled with the proliferation of telemedicine platforms and online pharmacies, contributes to this phenomenon. Many people are injecting various types of peptides, guided by information found on social media and online forums, for purposes such as increasing muscle mass, accelerating metabolism, or reducing wrinkles. However, for many of these peptides, robust research on their safety and efficacy in humans is still lacking. For instance, peptides like BPC-157, despite promising animal studies, lack approved formulations, validated dosages, and completed phase two clinical trials for human use. Similarly, GHK-Cu, a peptide showing promise in collagen production and tissue repai... 
